🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nisha Rao

Johns Hopkins University

ORCID: 0009-0003-6833-1922

Also affiliated with Johns Hopkins Medicine, Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center, University of Baltimore

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses”.

Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses

Nature Medicine(2024)10.1038/s41591-024-02877-z
N/A
2.2DataRank · unranked
113 citations

Blair V. Landon, Ali H. Zaidi, Dipika Singh, Jenna VanLiere Canzoniero, Archana Balan +26 more

Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1469
N/A
0.538DataRank · unranked
35 citations

Lavanya Sivapalan, Karlijn Hummelink, Archana Balan, James R. White, Noushin Niknafs +28 more

Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.06.23.546338
N/A
0.261DataRank · unranked
3 citations

Lavanya Sivapalan, Karlijn Hummelink, Archana Balan, James R. White, Noushin Niknafs +25 more

Longitudinal tumor-informed cfDNA whole genome sequencing to capture residual disease during neoadjuvant immune checkpoint inhibition in resectable gastroesophageal cancer.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.2550
N/A
0.104DataRank · unranked
1 citations

Nisha Rao, Gavin Pereira, Noushin Niknafs, Mark Sausen, Ellen L. Verner +15 more